Med Ed 101

JULY 7, 2024

JS is a 45 year-old male who has been taking bupropion SR 150 mg twice daily for about 4 weeks. He has been taking it for depression. He reports that depressive symptoms have started to improve but he does notice that he has a harder time getting to sleep and staying asleep since beginning the […] The post Wellbutrin XL Versus Bupropion SR – Insomnia Rates appeared first on Med Ed 101.

105

105

pharmaphorum

JULY 7, 2024

Novartis, Pfizer, Otsuka and Novo Nordisk have been called out for breaching the ABPI code of practice

115

115

Pharmacy Times

JULY 7, 2024

In the 2 mg bulevirtide (Gilead Sciences) group, 44% of individuals achieved HDV RNA that was undetectable compared with 70% in the 10 mg group.

123

123

The FDA Law Blog

JULY 7, 2024

By Gail H. Javitt — In its final rule on laboratory developed tests (LDTs) (see our prior blog here ), FDA acknowledged that “some laboratories may lack familiarity, experience, or existing infrastructure for complying with FDA requirements” and made multiple references to a “small entity compliance guidance” that the agency intended to publish to “provide additional guidance to small businesses.

Labelling 64

Labelling FDA Communication Documentation 64

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.